Immunodeficiency and cancer: prospects for correction von Hadden, John W.

Volltext

Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer von Wolf, Gregory T., Fee Jr, Willard E., Dolan, Robert W., Moyer, Jeffrey S., Kaplan, Michael J., Spring, Paul M., Suen, James, Kenady, Daniel E., Newman, Jason G., Carroll, William R., Gillespie, M. Boyd, Freeman, Scott M., Baltzer, Lorraine, Kirkley, Terry D., Brandwein, Harvey J., Hadden, John W.

Volltext

Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic von Czystowska, Malgorzata, Szczepanski, Miroslaw J, Szajnik, Marta, Quadrini, Karen, Brandwein, Harvey, Hadden, John W, Whiteside, Theresa L

Volltext

Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen von Berinstein, Neil L., Wolf, Gregory T., Naylor, Paul H., Baltzer, Lorraine, Egan, James E., Brandwein, Harvey J., Whiteside, Theresa L., Goldstein, Lynn C., El-Naggar, Adel, Badoual, Cecile, Fridman, Wolf-Herve, White, J. Michael, Hadden, John W.

Volltext

Preclinical studies with IRX-2 and thymosin alpha 1 in combination therapy von Naylor, Paul H, Hadden, John W

Volltext

A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck von Freeman, Scott M, Franco, Jose Luis Barrera, Kenady, Daniel E, Baltzer, Lorraine, Roth, Zygmund, Brandwein, Harvey J, Hadden, John W

Volltext

A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma von Whiteside, Theresa L., Butterfield, Lisa H., Naylor, Paul H., Egan, James E., Hadden, John W., Baltzer, Lorraine, Wolf, Gregory T., Berinstein, Neil L.

Volltext

Immunopharmacology of Thymosin alpha 1 and Cytokine Synergy von Naylor, Paul H, Quadrini, Karen, GARACI, ENRICO, Rasi, Guido, Hadden, John W

Volltext

IRX-2 increases the T cell-specific immune response to protein/peptide vaccines von Naylor, Paul H, Hernandez, Karla E, Nixon, April E, Brandwein, Harvey J, Haas, Gabriel P, Wang, Ching Y, Hadden, John W

Volltext

IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro von EGAN, James E, QUADRINI, Karen J, SANTIAGO-SCHWARZ, Frances, HADDEN, John W, BRANDWEIN, Harvey J, SIGNORELLI, Kathy L

Volltext

T cell targeted immune enhancement yields effective T cell adjuvants von Naylor, Paul H., Hadden, John W.

Volltext

Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2 von Meneses, Abelardo, Verastegui, Emma, Barrera, Jose L, de la Garza, Jaime, Hadden, John W

Volltext

T cell immunostimulation by methyl inosine 5′-monophosphate: application to infectious diseases von Signorelli, Kathy L., Hadden, John W.

Volltext

Preclinical studies with IRX-2 and thymosin α1 in combination therapy von Naylor, Paul H., Hadden, John W.

Volltext

Protection by methyl inosine monophosphate (MIMP) against aerosol influenza virus infection in mice von Masihi, K.Noel, Hadden, John W.

Volltext

Preclinical studies with IRX-2 and thymosin [alpha]1 in combination therapy von Naylor, Paul H, Hadden, John W

Volltext

Aspects of the immunopharmacology of thymosin α1 von Hadden, John W

Volltext

Thymic Endocrinology von HADDEN, JOHN W.

Volltext

Zinc induces thymulin secretion from human thymic epithelial cells In vitro and augments splenocyte and thymocyte responses In vivo von Saha, Anutosh R., Hadden, Elba M., Hadden, John W.

Volltext

Immunopharmacology of Thymosin α1 and Cytokine Synergy von NAYLOR, PAUL H., QUADRINI, KAREN, GARACI, ENRICO, RASI, GUIDO, HADDEN, JOHN W.

Volltext